FindTrial
Sign In

Intervention using Zinc Lozenges preoperatively to reduce incidence of post operative sore throat.

A comparative study using zinc lozenges versus placebo for the prevention of post-operative sore throat in patients undergoing elective surgery under general anaesthesia: a prospective randomized controlled double blind trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039682
Enrollment
124
Registered
2022-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Zinc Lozenges vs Placebo: A cost-effective method to prevent incidence of sore throat using 55mg zinc sulfate lozenges.47.5 mg Zinc Sulfate lozenges -Chewables 30 minutes preoperatively

Sponsors

Other self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: INCLUSION CRITERIA: 1.AGE GROUP 18-60 YEARS 2.PATIENTS UNDER THE CATEGORY OF MMS CLASS I OR CLASS II. 3.PATIENTS BELONGING TO ASA I / ASA II 4.SURGERY DURATION OF 1- 4 HOURS 5.ELECTIVE SURGERY. 6.WILLINGNESS TO PARTICIPATE IN THIS STUDY

Exclusion criteria

Exclusion criteria: EXCLUSION CRITERIA 1.PATIENT REFUSAL 2.SURGERY FOR MORE THAN 4 HOURS 3.PATIENTS BELONGING TO ASA III OR IV 4.PATIENTS OF MMS CLASS III OR IV 4.EMERGENCY SURGERIES

Design outcomes

Primary

MeasureTime frame
A. To study the role and efficacy of zinc sulphate to reduce the incidence of post-operative sore throat. Timepoint: 2021 march to 2023 january—

Secondary

MeasureTime frame
To ascertain the severity of post-operative sore throat in the study population.Timepoint: 2023—

Countries

India

Contacts

Public ContactDrSparsha S Vasisht

SDM Medical Sciences And Hospital

shyamsunderkamath@yahoo.co.in9900413473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026